论文部分内容阅读
目的 :探讨双黄连注射液与青霉素治疗小儿肺炎临床疗效,并分析其安全性。方法 :研究对象为我院2014年5月至2015年5月期间收治的66例肺炎患儿,按随机数字表法分为观察组(n=33)与对照组(n=33),观察组患儿给予双黄连注射液治疗,对照组患儿给予青霉素治疗,对比两组治疗效果,并分析其用药安全性。结果 :观察组有效率为97.5%,对照组有效率为87.88%,观察组治疗效果显著优于对照组(P<0.05);观察组在患儿咳嗽消失时间、肺部啰音消失时间以及平均退热时间明显短于对照组(P<0.05)。结论 :针对小儿肺炎的治疗,双黄连注射液的疗效与青霉素相当,但双黄连注射液具有更好的预后效果,更具推广价值。
Objective: To investigate the clinical efficacy of Shuanghu Lianlian injection and penicillin in the treatment of children with pneumonia, and analyze its safety. Methods: Sixty-six children with pneumonia admitted from May 2014 to May 2015 in our hospital were divided into observation group (n = 33) and control group (n = 33) according to random number table method. The observation group Children were given Shuanghuanglian injection treatment, control group given penicillin treatment, the two groups compared the therapeutic effect and analysis of its drug safety. Results: The effective rate of the observation group was 97.5%, the effective rate of the control group was 87.88%, the observation group was significantly better than the control group (P <0.05); the observation group in the children cough disappear time, pulmonary rales disappear time and the average Antipyretic time was significantly shorter than the control group (P <0.05). Conclusion: For the treatment of pediatric pneumonia, shuanghuanglian injection has the same efficacy as penicillin, but Shuanghuanglian injection has better prognosis and more promotion value.